The Pistoia Alliance is examining the challenges of the Faster Safe Companion Diagnostics (CDx) by Aligning Discovery & Clinical Data in the Regulatory Domain.
The slides discuss whether the data standards used in the research environment be aligned better with the data standards used in the regulated environment? If so, the time and cost of the development of NGS-based CDx could be reduced.
Global next generation sequencing market size, share & forecast, 2025TechSci Research
According to www.techsciresearch.com latest Report- Global next-generation sequencing market is projected to grow at a CAGR of close to 20% to reach USD24 billion during the forecast period. Enhancing regulatory framework for next-generation sequencing based tests for diagnostics is the key factor for the growth of global next-generation sequencing market during the forecast period.
Report URL- https://www.techsciresearch.com/report/next-generation-sequencing-market/4508.html
Nano-Medicine Global MarketNano medicine global marketpharmaindexing
This document discusses the global market for nanomedicine. It begins by describing how nanotechnology has changed perspectives in science and healthcare, with potential applications in drug delivery, gene mimicking, diagnostics, and more. However, moving nanotechnology from the lab to approved products is an expensive, long process due to regulatory hurdles. While the future market seems promising, these challenges make investors reluctant to fund large projects. The document then reviews various types of nanomaterials and their uses, as well as market projections showing continued high growth in the nanomedicine sector driven primarily by anticancer drugs. Barriers to financing nanotechnology development are also discussed.
“Next-Generation Sequencing (NGS) Global Market – Forecast To 2022”Vinay Shiva Prasad
Next Generation Sequencing (NGS) has revolutionized the way the human genomes are being sequenced now a days. The time and cost to sequence has tremendously reduced . In the last five years, the sequencing cost has rapidly reduced and this is supposed to have a huge impact on the NGS market in the coming years.
Global gene therapy market & pipeline insightKuicK Research
“Global Gene Therapy Market & Pipeline Insight” Market Highlight:
Gene Therapy Market Overview
Significance of Gene Therapy in Cancer Therapeutics
Current Applications of Gene Therapy to Cancer Treatment
Gene Therapy Market Dynamics: Drivers, Challenges & Future Outlook
FDA & AMA Guidelines for Gene Therapy
Gene Therapy Pipeline by Phase, Indications, Country & Company
Gene Therapy Pipeline: 246 Drugs
Marketed Gene Therapy: 2 (Gendicine & Rexin-G)
Cancer Gene Therapy Pipeline: 69 Drugs
"Global HIV Vaccine Market Future Outlook" Report Highlights:
Introduction to HIV Vaccines
Issues Related to the Development of HIV Vaccines
Parameters for Successful Commercialization of HIV Vaccines
Global HIV Vaccines Market Opportunity Analysis
Global HIV Vaccine Clinical Pipeline by Company & Phase
Global HIV Vaccine Clinical Pipeline: 100 Vaccines
Majority Vaccine in Preclinical Phase: 42 Vaccines
Global cancer tyrosine kinase inhibitors market & clinical pipeline outlo...KuicK Research
This document provides an overview of the global cancer tyrosine kinase inhibitors market and clinical pipeline outlook for 2020. It discusses tyrosine kinases' role in cancer signaling pathways and the development of tyrosine kinase inhibitors as targeted cancer therapies. The market for tyrosine kinase inhibitors is growing due to rising cancer incidence and a strong clinical pipeline. Over 400 tyrosine kinase inhibitors are in clinical development globally across various phases of trials. The future outlook for tyrosine kinase inhibitors is optimistic due to ongoing research and advancement in development approaches.
The Pistoia Alliance is examining the challenges of the Faster Safe Companion Diagnostics (CDx) by Aligning Discovery & Clinical Data in the Regulatory Domain.
The slides discuss whether the data standards used in the research environment be aligned better with the data standards used in the regulated environment? If so, the time and cost of the development of NGS-based CDx could be reduced.
Global next generation sequencing market size, share & forecast, 2025TechSci Research
According to www.techsciresearch.com latest Report- Global next-generation sequencing market is projected to grow at a CAGR of close to 20% to reach USD24 billion during the forecast period. Enhancing regulatory framework for next-generation sequencing based tests for diagnostics is the key factor for the growth of global next-generation sequencing market during the forecast period.
Report URL- https://www.techsciresearch.com/report/next-generation-sequencing-market/4508.html
Nano-Medicine Global MarketNano medicine global marketpharmaindexing
This document discusses the global market for nanomedicine. It begins by describing how nanotechnology has changed perspectives in science and healthcare, with potential applications in drug delivery, gene mimicking, diagnostics, and more. However, moving nanotechnology from the lab to approved products is an expensive, long process due to regulatory hurdles. While the future market seems promising, these challenges make investors reluctant to fund large projects. The document then reviews various types of nanomaterials and their uses, as well as market projections showing continued high growth in the nanomedicine sector driven primarily by anticancer drugs. Barriers to financing nanotechnology development are also discussed.
“Next-Generation Sequencing (NGS) Global Market – Forecast To 2022”Vinay Shiva Prasad
Next Generation Sequencing (NGS) has revolutionized the way the human genomes are being sequenced now a days. The time and cost to sequence has tremendously reduced . In the last five years, the sequencing cost has rapidly reduced and this is supposed to have a huge impact on the NGS market in the coming years.
Global gene therapy market & pipeline insightKuicK Research
“Global Gene Therapy Market & Pipeline Insight” Market Highlight:
Gene Therapy Market Overview
Significance of Gene Therapy in Cancer Therapeutics
Current Applications of Gene Therapy to Cancer Treatment
Gene Therapy Market Dynamics: Drivers, Challenges & Future Outlook
FDA & AMA Guidelines for Gene Therapy
Gene Therapy Pipeline by Phase, Indications, Country & Company
Gene Therapy Pipeline: 246 Drugs
Marketed Gene Therapy: 2 (Gendicine & Rexin-G)
Cancer Gene Therapy Pipeline: 69 Drugs
"Global HIV Vaccine Market Future Outlook" Report Highlights:
Introduction to HIV Vaccines
Issues Related to the Development of HIV Vaccines
Parameters for Successful Commercialization of HIV Vaccines
Global HIV Vaccines Market Opportunity Analysis
Global HIV Vaccine Clinical Pipeline by Company & Phase
Global HIV Vaccine Clinical Pipeline: 100 Vaccines
Majority Vaccine in Preclinical Phase: 42 Vaccines
Global cancer tyrosine kinase inhibitors market & clinical pipeline outlo...KuicK Research
This document provides an overview of the global cancer tyrosine kinase inhibitors market and clinical pipeline outlook for 2020. It discusses tyrosine kinases' role in cancer signaling pathways and the development of tyrosine kinase inhibitors as targeted cancer therapies. The market for tyrosine kinase inhibitors is growing due to rising cancer incidence and a strong clinical pipeline. Over 400 tyrosine kinase inhibitors are in clinical development globally across various phases of trials. The future outlook for tyrosine kinase inhibitors is optimistic due to ongoing research and advancement in development approaches.
Molecular diagnostics in infectious disease testingReportsnReports
This document provides an overview of the molecular diagnostics market for infectious disease testing. It describes how molecular diagnostics offers powerful techniques for diagnosing infectious diseases through detection of nucleic acids, overcoming limitations of previous culture-based methods. The infectious disease sector represents the largest and most profitable part of the molecular diagnostics market. The report examines key technologies, market sizes and forecasts, drivers and restraints, and competitive landscapes for major infectious diseases like HIV, hepatitis, HPV, influenza, and more. It also discusses emerging opportunities in molecular diagnostic tools, multiplex testing, and next generation sequencing.
Next Generation Sequencing Market, By Types of Test, Companies, ForecastNehaSingh522734
Next Generation Sequencing Market will reach US$ 34.8 Billion by 2027. Global Forecast, Impact of COVID-19, Industry Trends, Growth, Opportunity By Types of Test, Company Analysis.
Sona Nanotech is a nanotechnology life sciences firm that has developed multiple proprietary methods for the manufacture of various types of gold nanoparticles. The principal business carried out and intended to be continued by Sona is the development and application of its proprietary technologies for use in multiplex diagnostic testing platforms that will improve performance over existing tests in the market. Sona Nanotech's gold nanorod particles are cetyltrimethylammonium free, eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. It is expected that Sona Nanotech's gold nanotechnologies may be adapted for use in applications as a safe and effective delivery system for multiple medical treatments, subject to the approval of various regulatory boards, including Health Canada and the FDA.
"US Cancer Vaccine Market Outlook 2020" Report Highlight:
US Cancer Vaccine Market Analysis
Cancer Vaccine with Orphan Status
US Cancer Vaccine Clinical Pipeline by Company, Indication & Phase
US Cancer Vaccine Clinical Pipeline: 187 Vaccines
Clinical Insight of Marketed Cancer Vaccines in US
Marketed Cancer Vaccine in US: 5 Vaccines
FDA Regulations for Clinical Trials of Cancer Vaccines
This SlideShare gives an overview on how a drug is discovered, researched, developed, tested and reviewed for approval. It follows the current standard of approval set by the Food and Drug Administration (FDA), a federal agency of the United States Department of Health and Human Services. The process is generally divided into 4 Stages: Pre-Clinical, Clinical, New Drug Application (NDA) Review & Post-Marketing.
Cancer Diagnostics Reference Laboratory / NeoGenomics April 2014 investors company overview presentation. This presentation highlights the following:
--Fast growing cancer genetics lab servicing Oncologists, Pathologists and Hostpitals
--Strategic client partnerships created by "Tech-Only" model
--Dynamic, rapidly-growing and consolidating industry
Industry-leading revenue & test volume growth
--Strong productivity and operating leverage leading to accelerating cash flow and net income
--Strong Management Team with large cap lab experience
Cancer cd antigen inhibitors market & pipeline insight2015KuicK Research
“Cancer CD Antigens Inhibitors Therapy Market & Pipeline Insight 2015” Report Highlight:
Nomenclature & Classification of CD Antigens
Mechanism of CD Antigen Cancer Therapeutics
Cancer CD Antigen Therapy Market Overview
Cancer CD Antigen Inhibitors Clinical Pipeline by Company, Indication & Phase
Cancer CD Antigen Inhibitors Clinical Pipeline: 207 Drugs
Marketed Cancer CD Antigen Inhibitors: 27 Drugs
Majority of Cancer CD Antigen Inhibitors in Preclinical Phase: 70 Drugs
Cancer CD Antigens Clinical Pipeline Dominated by CD20 Antigen: 44 Drugs
Cancer CD Antigens Clinical Pipeline is Represented in 52 Graphs & Charts
The document summarizes recent advances at Inovio Pharmaceuticals, including being selected as a top translational researcher, generating immune responses in head and neck cancer patients, and protecting animals from Zika infection. It then discusses Inovio's plans to initiate a phase III trial for its HPV immunotherapy in 1H17 after an FDA request for additional information, and its partnership with MedImmune to develop immuno-oncology combination therapies. The document provides an overview of Inovio's immunotherapy technology platform and its potential applications in infectious diseases and cancer.
The document summarizes Inovio Pharmaceuticals' immunotherapy platform and development pipeline. Key points include:
1) Inovio is developing DNA-based immunotherapies and vaccines to treat cancers and infectious diseases using its SynCon platform and CELLECTRA delivery device.
2) Its lead product, VGX-3100 for HPV-related diseases, achieved efficacy in a phase II trial and plans to start a phase III trial in 2017.
3) Inovio is also developing immunotherapies for immuno-oncology including combination trials with checkpoint inhibitors starting in 2017.
4) It has infectious disease vaccines in development for Ebola, MERS, Zika
Inovio is developing DNA-based immunotherapies and vaccines to treat cancers and infectious diseases. They have demonstrated efficacy of their VGX-3100 immunotherapy in a phase II trial for HPV-related cervical dysplasia. Inovio plans to start a phase III trial for VGX-3100 in 2017 and pursue other HPV-related indications. They are also developing immunotherapies for cancers in combination with checkpoint inhibitors, with a phase I/II trial starting in early 2017. In addition, Inovio is developing vaccines for infectious diseases like HIV, Ebola, Zika, and hepatitis B, with phase I data expected in 2017 that could support further development.
Dr. Joseph Kim, President & CEO of Inovio Pharmaceuticals, discussed Inovio's progress in developing DNA immunotherapies to treat cancers and infectious diseases. Key highlights included Phase II clinical trial results for VGX-3100 showing it met efficacy endpoints for treating HPV-related cervical dysplasia, additional cancer trials starting in 2014, and the potential for Inovio's therapies to provide non-surgical treatments and preventive vaccines. Inovio is a global leader in active immune therapies and aims to transform the fight against diseases through its SynCon DNA immunotherapy platform.
This document is a dissertation that evaluates the market potential of next-generation genetically modified (GM) vaccines to address unmet medical needs, with a focus on influenza vaccines. The dissertation conducts several studies to identify critical success factors for GM vaccines and analyze trends in GM vaccine patents, approvals, and technologies. It focuses particularly on the potential of the modified vaccinia virus Ankara (MVA) vector platform and conducts interviews with key opinion leaders in vaccine development to understand challenges to market implementation. The data suggest that vector-based GM vaccines may offer a cost-effective way to produce safe and effective vaccines for diseases that currently lack vaccines, helping fulfill an important unmet medical need.
Global peptide vaccine market & pipeline insightKuicK Research
Global Peptide Vaccine Market & Pipeline Insight provides an overview of the global peptide vaccine market and pipeline. Peptide vaccines work by activating the human immune system through mimicking pathogen proteins, inducing long-term immunity without showing direct pharmacological effects. The research and development of peptide vaccines has gained significant momentum in the pharmaceutical industry over the past decade due to their high safety, efficacy, and minimal side effects. The report provides details on the peptide vaccine market size and dynamics, clinical pipeline by phase and indication, and competitive landscape among major industry players. It is expected that next-generation peptide vaccines currently in development will pass regulatory approvals and clinical trials to be commercialized in the near future.
Global cancer vaccine market & clinical trial insightKuicK Research
The document discusses global cancer vaccine market and clinical trials. It provides an overview of the history and development of cancer vaccines. Currently, there are a range of cancer therapeutics available but they have limitations like low effectiveness and specificity. Researchers have developed cancer vaccines to alleviate patient suffering and they work by activating the immune system to attack cancer cells. There are now numerous cancer vaccines in clinical trials for different cancer types. Several have also been approved and are available commercially. The market for cancer vaccines is growing due to factors like fewer side effects, specificity, and innovations in delivery methods. Many companies are actively investing in developing new cancer vaccines.
Global vaccine market Keyword Market PPT 2021-26 | Enhancing Huge Growth and ...IMARC Group
According to the latest report by IMARC Group the global vaccine market size reached a strong growth in 2020.One of the leading trends witnessed in the global vaccines market is the surging cases of the coronavirus disease (COVID-19), which has, till date, resulted in the loss of around half a million lives around the world Looking forward, the market value is projected to reach a strong growth during the forecast period (2021-2026).
Global oncolytic virus therapy market & pipeline outlook 2022Rajesh Sarma
“Global Oncolytic Virus Therapy Market & Pipeline Outlook 2022” report analyzes ongoing clinical and non-clinical trends in the oncolytic virus therapy market. Currently there are 2 oncolytic virus therapies commercially available in the market. This report analyzes the ongoing clinical trial of 48 oncolytic virus therapies in clinical pipeline and gives comprehensive clinical insight on various parameters associated with the development of the oncolytic virus therapies. Most of the oncolytic virus therapy in clinical trials are in preclinical phase followed by Phase-I trials.
10 most trusted clinical laboratories in 2021Merry D'souza
To honor the diligent services of clinical laboratories, we came up with this edition of Insights Care - 10 Most Trusted Clinical Laboratories in 2021.
1. The document provides steps to develop a free knowledge management system in Eclipse, including downloading Eclipse and importing a knowledge source directory, downloading and configuring Tomcat, and installing additional frontend libraries like Node.js, Bower, and the frontend library using the bower install command.
2. It instructs the user to download Eclipse from its website, start Eclipse, import the knowledge source directory, download and import Tomcat into Eclipse, configure Tomcat settings, and start Tomcat to view the knowledge system at http://localhost:8080/knowledge.
3. Additional steps include installing Node.js from its website, using npm to install Bower for the frontend, and running bower install to retrieve the
This document contains tweets and posts from @Agileleachy about agile product development principles. It discusses developing a minimum viable product to test assumptions, focusing on delivering value to customers, reducing complexity, failing fast through experimentation, and obtaining early customer feedback to guide the product vision. The overall message is that agile practices like iterative development and customer-centric prioritization help create successful products.
High Fidelity prototyping tools Axure RP and Crank Storyboard Suite allow designers to create interactive prototypes that demonstrate the look, feel and functionality of a design. Both tools enable building clickable wireframes and mockups to gather feedback before development begins. They help ensure designs meet requirements before resources are spent on development.
This document discusses how to develop effective online product training courses. It notes that traditional classroom training has challenges, so online courses are better for reaching global audiences and allowing flexible, self-paced learning. It provides strategies for course design like using short modules, videos, and assessments. Finally, it reviews authoring tools like Articulate Storyline, Studio, and Captivate that can help non-programmers easily create interactive online training content.
Molecular diagnostics in infectious disease testingReportsnReports
This document provides an overview of the molecular diagnostics market for infectious disease testing. It describes how molecular diagnostics offers powerful techniques for diagnosing infectious diseases through detection of nucleic acids, overcoming limitations of previous culture-based methods. The infectious disease sector represents the largest and most profitable part of the molecular diagnostics market. The report examines key technologies, market sizes and forecasts, drivers and restraints, and competitive landscapes for major infectious diseases like HIV, hepatitis, HPV, influenza, and more. It also discusses emerging opportunities in molecular diagnostic tools, multiplex testing, and next generation sequencing.
Next Generation Sequencing Market, By Types of Test, Companies, ForecastNehaSingh522734
Next Generation Sequencing Market will reach US$ 34.8 Billion by 2027. Global Forecast, Impact of COVID-19, Industry Trends, Growth, Opportunity By Types of Test, Company Analysis.
Sona Nanotech is a nanotechnology life sciences firm that has developed multiple proprietary methods for the manufacture of various types of gold nanoparticles. The principal business carried out and intended to be continued by Sona is the development and application of its proprietary technologies for use in multiplex diagnostic testing platforms that will improve performance over existing tests in the market. Sona Nanotech's gold nanorod particles are cetyltrimethylammonium free, eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. It is expected that Sona Nanotech's gold nanotechnologies may be adapted for use in applications as a safe and effective delivery system for multiple medical treatments, subject to the approval of various regulatory boards, including Health Canada and the FDA.
"US Cancer Vaccine Market Outlook 2020" Report Highlight:
US Cancer Vaccine Market Analysis
Cancer Vaccine with Orphan Status
US Cancer Vaccine Clinical Pipeline by Company, Indication & Phase
US Cancer Vaccine Clinical Pipeline: 187 Vaccines
Clinical Insight of Marketed Cancer Vaccines in US
Marketed Cancer Vaccine in US: 5 Vaccines
FDA Regulations for Clinical Trials of Cancer Vaccines
This SlideShare gives an overview on how a drug is discovered, researched, developed, tested and reviewed for approval. It follows the current standard of approval set by the Food and Drug Administration (FDA), a federal agency of the United States Department of Health and Human Services. The process is generally divided into 4 Stages: Pre-Clinical, Clinical, New Drug Application (NDA) Review & Post-Marketing.
Cancer Diagnostics Reference Laboratory / NeoGenomics April 2014 investors company overview presentation. This presentation highlights the following:
--Fast growing cancer genetics lab servicing Oncologists, Pathologists and Hostpitals
--Strategic client partnerships created by "Tech-Only" model
--Dynamic, rapidly-growing and consolidating industry
Industry-leading revenue & test volume growth
--Strong productivity and operating leverage leading to accelerating cash flow and net income
--Strong Management Team with large cap lab experience
Cancer cd antigen inhibitors market & pipeline insight2015KuicK Research
“Cancer CD Antigens Inhibitors Therapy Market & Pipeline Insight 2015” Report Highlight:
Nomenclature & Classification of CD Antigens
Mechanism of CD Antigen Cancer Therapeutics
Cancer CD Antigen Therapy Market Overview
Cancer CD Antigen Inhibitors Clinical Pipeline by Company, Indication & Phase
Cancer CD Antigen Inhibitors Clinical Pipeline: 207 Drugs
Marketed Cancer CD Antigen Inhibitors: 27 Drugs
Majority of Cancer CD Antigen Inhibitors in Preclinical Phase: 70 Drugs
Cancer CD Antigens Clinical Pipeline Dominated by CD20 Antigen: 44 Drugs
Cancer CD Antigens Clinical Pipeline is Represented in 52 Graphs & Charts
The document summarizes recent advances at Inovio Pharmaceuticals, including being selected as a top translational researcher, generating immune responses in head and neck cancer patients, and protecting animals from Zika infection. It then discusses Inovio's plans to initiate a phase III trial for its HPV immunotherapy in 1H17 after an FDA request for additional information, and its partnership with MedImmune to develop immuno-oncology combination therapies. The document provides an overview of Inovio's immunotherapy technology platform and its potential applications in infectious diseases and cancer.
The document summarizes Inovio Pharmaceuticals' immunotherapy platform and development pipeline. Key points include:
1) Inovio is developing DNA-based immunotherapies and vaccines to treat cancers and infectious diseases using its SynCon platform and CELLECTRA delivery device.
2) Its lead product, VGX-3100 for HPV-related diseases, achieved efficacy in a phase II trial and plans to start a phase III trial in 2017.
3) Inovio is also developing immunotherapies for immuno-oncology including combination trials with checkpoint inhibitors starting in 2017.
4) It has infectious disease vaccines in development for Ebola, MERS, Zika
Inovio is developing DNA-based immunotherapies and vaccines to treat cancers and infectious diseases. They have demonstrated efficacy of their VGX-3100 immunotherapy in a phase II trial for HPV-related cervical dysplasia. Inovio plans to start a phase III trial for VGX-3100 in 2017 and pursue other HPV-related indications. They are also developing immunotherapies for cancers in combination with checkpoint inhibitors, with a phase I/II trial starting in early 2017. In addition, Inovio is developing vaccines for infectious diseases like HIV, Ebola, Zika, and hepatitis B, with phase I data expected in 2017 that could support further development.
Dr. Joseph Kim, President & CEO of Inovio Pharmaceuticals, discussed Inovio's progress in developing DNA immunotherapies to treat cancers and infectious diseases. Key highlights included Phase II clinical trial results for VGX-3100 showing it met efficacy endpoints for treating HPV-related cervical dysplasia, additional cancer trials starting in 2014, and the potential for Inovio's therapies to provide non-surgical treatments and preventive vaccines. Inovio is a global leader in active immune therapies and aims to transform the fight against diseases through its SynCon DNA immunotherapy platform.
This document is a dissertation that evaluates the market potential of next-generation genetically modified (GM) vaccines to address unmet medical needs, with a focus on influenza vaccines. The dissertation conducts several studies to identify critical success factors for GM vaccines and analyze trends in GM vaccine patents, approvals, and technologies. It focuses particularly on the potential of the modified vaccinia virus Ankara (MVA) vector platform and conducts interviews with key opinion leaders in vaccine development to understand challenges to market implementation. The data suggest that vector-based GM vaccines may offer a cost-effective way to produce safe and effective vaccines for diseases that currently lack vaccines, helping fulfill an important unmet medical need.
Global peptide vaccine market & pipeline insightKuicK Research
Global Peptide Vaccine Market & Pipeline Insight provides an overview of the global peptide vaccine market and pipeline. Peptide vaccines work by activating the human immune system through mimicking pathogen proteins, inducing long-term immunity without showing direct pharmacological effects. The research and development of peptide vaccines has gained significant momentum in the pharmaceutical industry over the past decade due to their high safety, efficacy, and minimal side effects. The report provides details on the peptide vaccine market size and dynamics, clinical pipeline by phase and indication, and competitive landscape among major industry players. It is expected that next-generation peptide vaccines currently in development will pass regulatory approvals and clinical trials to be commercialized in the near future.
Global cancer vaccine market & clinical trial insightKuicK Research
The document discusses global cancer vaccine market and clinical trials. It provides an overview of the history and development of cancer vaccines. Currently, there are a range of cancer therapeutics available but they have limitations like low effectiveness and specificity. Researchers have developed cancer vaccines to alleviate patient suffering and they work by activating the immune system to attack cancer cells. There are now numerous cancer vaccines in clinical trials for different cancer types. Several have also been approved and are available commercially. The market for cancer vaccines is growing due to factors like fewer side effects, specificity, and innovations in delivery methods. Many companies are actively investing in developing new cancer vaccines.
Global vaccine market Keyword Market PPT 2021-26 | Enhancing Huge Growth and ...IMARC Group
According to the latest report by IMARC Group the global vaccine market size reached a strong growth in 2020.One of the leading trends witnessed in the global vaccines market is the surging cases of the coronavirus disease (COVID-19), which has, till date, resulted in the loss of around half a million lives around the world Looking forward, the market value is projected to reach a strong growth during the forecast period (2021-2026).
Global oncolytic virus therapy market & pipeline outlook 2022Rajesh Sarma
“Global Oncolytic Virus Therapy Market & Pipeline Outlook 2022” report analyzes ongoing clinical and non-clinical trends in the oncolytic virus therapy market. Currently there are 2 oncolytic virus therapies commercially available in the market. This report analyzes the ongoing clinical trial of 48 oncolytic virus therapies in clinical pipeline and gives comprehensive clinical insight on various parameters associated with the development of the oncolytic virus therapies. Most of the oncolytic virus therapy in clinical trials are in preclinical phase followed by Phase-I trials.
10 most trusted clinical laboratories in 2021Merry D'souza
To honor the diligent services of clinical laboratories, we came up with this edition of Insights Care - 10 Most Trusted Clinical Laboratories in 2021.
1. The document provides steps to develop a free knowledge management system in Eclipse, including downloading Eclipse and importing a knowledge source directory, downloading and configuring Tomcat, and installing additional frontend libraries like Node.js, Bower, and the frontend library using the bower install command.
2. It instructs the user to download Eclipse from its website, start Eclipse, import the knowledge source directory, download and import Tomcat into Eclipse, configure Tomcat settings, and start Tomcat to view the knowledge system at http://localhost:8080/knowledge.
3. Additional steps include installing Node.js from its website, using npm to install Bower for the frontend, and running bower install to retrieve the
This document contains tweets and posts from @Agileleachy about agile product development principles. It discusses developing a minimum viable product to test assumptions, focusing on delivering value to customers, reducing complexity, failing fast through experimentation, and obtaining early customer feedback to guide the product vision. The overall message is that agile practices like iterative development and customer-centric prioritization help create successful products.
High Fidelity prototyping tools Axure RP and Crank Storyboard Suite allow designers to create interactive prototypes that demonstrate the look, feel and functionality of a design. Both tools enable building clickable wireframes and mockups to gather feedback before development begins. They help ensure designs meet requirements before resources are spent on development.
This document discusses how to develop effective online product training courses. It notes that traditional classroom training has challenges, so online courses are better for reaching global audiences and allowing flexible, self-paced learning. It provides strategies for course design like using short modules, videos, and assessments. Finally, it reviews authoring tools like Articulate Storyline, Studio, and Captivate that can help non-programmers easily create interactive online training content.
The document discusses using Bourdieu's framework to analyze market DNA through qualitative and quantitative research. It examines consumption indicators and key products to map categories and industries. Gap analyses include social media, benchmarks, and surveys to understand shifts in consumption behavior and their implications. While a flexible and scalable solution, limitations include a lack of consumer behavior data, inappropriate product links, cultural differences, and high data maintenance costs.
This document discusses how to develop products with a growth approach rather than being feature-driven. It recommends focusing on goals and key results rather than features by using an OKR framework. Ideas should be prioritized and tested using a score based on metrics like impact, ease of implementation, and ability to reach users. Regular testing and analysis of results should inform reprioritization of the backlog to focus on improving key metrics like activation, retention and revenue. The process emphasizes continuous learning and improving based on feedback from users.
This document provides guidance on developing effective presentation skills for marketing managers. It covers three key areas: developing great content by analyzing the audience, gathering relevant data, and creating an outline; creating a great design with consistent layout, color, and formatting; and delivering with a strong voice, body language, and ability to handle tough situations. The document emphasizes preparation, practice, and flexibility to create polished presentations.
The document discusses biomarkers and their use in disease diagnosis, drug development, and other applications. It provides an overview of the global biomarkers market, expected to reach $30.6 billion by 2020, with disease diagnosis as the major application. The market is analyzed by type, application, services, and geography. Key players in the biomarkers industry are also profiled.
Molecular diagnostics market & forecast (by application, technology, countrie...Renub Research
Renub Research (http://renub.com/report/molecular-diagnostics-market-forecast-by-application-technology-countries-companies-clinical-trials-to-2017-global-analysis-114) has announced the addition of the "Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies & Clinical Trials) to 2017: Global Analysis" report to its offering
Epigenetics Diagnostic Market Size, Share, Growth, Trends and Forecast Report...Signitech
The global epigenetics diagnostic market size was valued at USD 5.5 billion in 2018 and is estimated to register a CAGR of 18.8% over the forecast period. Increasing prevalence of cancer and other chronic diseases and growing geriatric population are some of the key factors expected to drive the market.
Oncology Molecular Diagnostics Market PPT: Growth, Outlook, Demand, Keyplayer...IMARC Group
The global oncology molecular diagnostics market size reached US$ 4.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 13.1 Billion by 2032, exhibiting a growth rate (CAGR) of 13% during 2024-2032.
More Info:- https://www.imarcgroup.com/oncology-molecular-diagnostics-market
Europe DNA Sequencing Products Market by Product Type, Distribution Channel, ...IMARC Group
The Europe DNA sequencing products market size reached US$ 1.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.7 Billion by 2028, exhibiting a growth rate (CAGR) of 16.7% during 2023-2028.
More Info:- https://www.imarcgroup.com/europe-dna-sequencing-products-market
DNA Methylation Market Growth, Demand and Challenges of the Key Industry Play...IMARC Group
The global DNA methylation market size reached US$ 1.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.5 Billion by 2032, exhibiting a growth rate (CAGR) of 13.5% during 2024-2032.
More Info:- https://www.imarcgroup.com/dna-methylation-market
The document discusses RNA-based therapeutics as a promising treatment option for chronic diseases. It summarizes that RNA-based therapies work using RNA interference technology or antisense technology to target specific genes. The market is segmented by technology, application, end-users and geography, with RNA interference technology currently dominating. While in the clinical research phase, RNA-based therapeutics show potential for diseases that are difficult to treat using existing options.
DNA microarrays are used to analyze gene expression levels or genotype multiple regions of DNA simultaneously. They apply the approach to drug research, clinical diagnosis, agriculture, and other sectors. However, the high costs and limited awareness of arrays hamper market growth. The report provides an in-depth analysis of the global array market, including market segmentation by type, end user, region, and key companies in the industry.
Global in vitro diagnostics (ivd) market (technique, product, usability, appl...Allied Market Research
The in vitro diagnostics market is expected to reach $74.65 billion by 2020, growing at a rate of 5.34% annually from $53.32 billion in 2013. North America currently generates the highest revenue, while Asia Pacific is the fastest growing region. Key drivers are increasing healthcare spending and advancements in diagnostic technologies. Hospitals and laboratories are the largest end users. The report provides an in-depth analysis of the market size, trends, opportunities, and competitive landscape by technique, product type, application, end user, and region.
India Molecular Diagnostics Market: Unveiling Competition, Size, and Robust G...Kumar Satyam
According to the TechSci Research report titled “India Molecular Diagnostics Market - Industry Size, Share, Trends, Competition Forecast & Opportunities, 2029,” the India Molecular Diagnostics Market was valued at USD 920.05 million in 2023 and is projected to grow at a CAGR of 8.15% during the forecast period from 2025 to 2029. This robust growth can be attributed to several factors, including the increasing prevalence of infectious diseases and genetic disorders, rising awareness and acceptance of personalized medicine and companion diagnostics, and significant advancements in molecular techniques. Additionally, improvements in healthcare infrastructure, increased healthcare expenditure, and growing demand for early and accurate disease diagnosis are also stimulating market growth. Government initiatives promoting precision medicine and genetic testing further contribute to the market's expansion.
Recent Trends in the India Molecular Diagnostics Market
Technological Advancements
The field of molecular diagnostics is evolving rapidly, with significant technological advancements enhancing diagnostic accuracy and efficiency. Techniques such as next-generation sequencing (NGS) and polymerase chain reaction (PCR) are at the forefront of this transformation. NGS allows for comprehensive genetic analysis, enabling the detection of mutations and variations associated with various diseases, including cancers and inherited disorders. PCR, known for its sensitivity and specificity, is widely used for detecting infectious agents and genetic mutations.
The global sexually transmitted disease (STD) diagnostics market size reached US$ 104.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 159.5 Billion by 2032, exhibiting a growth rate (CAGR) of 4.71% during 2024-2032.
More Info:- https://www.imarcgroup.com/sexually-transmitted-disease-diagnostics-market
DNA Sequencing Products Market by Product Type, Distribution Channel, End Use...IMARC Group
The global DNA sequencing products market size reached US$ 6.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 11.4 Billion by 2028, exhibiting a growth rate (CAGR) of 9.76% during 2023-2028.
More Info:- https://www.imarcgroup.com/dna-sequencing-products-market
Label-Free Detection Technology Market Research Report 2030.pdfAryan Mishra
Globally, the North American region was the dominant user of label-free detection technology in the last few years, and it will retain its dominance in the foreseeable future as well.
Recombinant DNA Technology Market by Product Type, Distribution Channel, End ...IMARC Group
The global recombinant DNA technology market size reached US$ 729.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 966.8 Billion by 2028, exhibiting a growth rate (CAGR) of 4.7% during 2023-2028.
More Info:- https://www.imarcgroup.com/recombinant-dna-technology-market
Biochip Market - Overview and Growth ReportSignitech
Global biochip market was valued at USD 7.63 billion in 2015. Presence of strong demand for proteomics - and genomics research-oriented products along with a comprehensive drug development pipeline is expected to drive growth in revenue.
Viral Vector and Plasmid DNA Manufacturing Market Insights, 2019 to 2025Signitech
The global viral vector and plasmid DNA manufacturing market size was valued at USD 270.2 million in 2017.It is anticipated to witness a CAGR of about 16.0% during the forecast period.
The document discusses the current state and expected growth trends of the in vitro diagnostics (IVD) market. It notes that the global IVD market was estimated at $54.2 billion in 2013 and is expected to grow 4% annually to $64.3 billion by 2018. Technological advances in areas like genomics, bioinformatics, and miniaturization have transformed diagnostic laboratory technology in recent years. Personalized medicine, infectious disease testing, and other applications are driving growth in the IVD market. However, economic instability, rising healthcare costs, and reimbursement changes pose challenges for the industry.
Nanotechnology in Healthcare Sector - A Perspective of BiosensorsYang FENG
1. The document discusses nanotechnology applications in the healthcare sector, specifically biosensors. It outlines various market segments and provides statistics on market size and growth rates.
2. It analyzes IMRE's research capabilities and publications related to biosensor development, which involve using nanomaterials like carbon nanotubes and nanoparticles.
3. The document proposes a closed-loop approach to developing biosensors using NEMS and strengthened collaboration between IMRE and other local and international institutes.
Blood culture test market Research, Industry Trends, Strategies, Growth, Regi...IMARC Group
The document provides information about IMARC Group, a market research firm. It details their expertise in areas such as market intelligence, business insights, competitive intelligence, strategy consulting, consumer surveys, and market entry strategies. It serves various industries including food and beverages, chemicals, FMCG, healthcare, machinery, and others. The document also highlights testimonials from clients praising IMARC's domain expertise, data provision for any market, and ability to provide innovative solutions.
India Cancer Diagnostics Market: Size, Share, and In-Depth Competitive Analys...Kumar Satyam
According to the TechSci Research report, “India Cancer Diagnostics Market –Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028,” the India Cancer Diagnostics Market stood at USD 571.03 billion in 2022 and is anticipated to grow with a CAGR of 7.36% in the forecast period, 2024-2028. Awareness among individuals regarding cancer diagnostics has led to favorable market conditions for the India Cancer Diagnostics market. Several factors contribute to the growth of various cancer diagnostics products, including advancements in technology, government initiatives, and increased healthcare investments.
Market Dynamics
Rising Incidence of Cancer
In 2022, the projected number of new cancer cases in India was 1,461,427, with a crude incidence rate of 100.4 per 100,000 individuals. Approximately one in nine people in India is expected to face a cancer diagnosis during their lifetime. Notably, lung cancer ranked highest among males, while breast cancer held the top spot for females. Within childhood cancers (0-14 years), lymphoid leukemia emerged as the predominant site, accounting for 29.2% in boys and 24.2% in girls. Looking ahead, an estimated 12.8% increase in cancer incidence by 2025 is expected compared to 2020.
Similar to Dna diagnostics market is making footprints across the globe (20)
Wireless charging is the transmission of energy without wires from a power source to a consuming device. Wireless charging devices comprise a charging station (or transmitter) that transmits the energy, and a receiver (integrated inside a device) that receives the energy and charges the battery.
The document summarizes a report on the global cloud identity access management (IAM) market from 2014 to 2020. It finds that the market is expected to reach $2.8 billion by 2020, growing at a CAGR of 26.2%. Cloud IAM provides secure identity-based access across industries in a cost-effective manner compared to traditional IAM. Key drivers are increased cyberattacks, regulations, and digital identities. North America generates the highest revenue currently.
Although high installation cost and lack of awareness regarding the long-term benefits of roofing systems are some factors, hindering the growth of roofing products, continuous innovation and rise in growth of building and construction sector provides a great potential for market expansion.
Bio-Alcohols Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $11,574 million by 2022, registering a CAGR of 8.6% during the period 2014-2022. Bioethanol is the largest segment by type and is expected to grow at a CAGR of 7.6% during the forecast period, in terms of revenue.
Factors that drive the growth of the bio-alcohols market are, the demand for greener fuel coupled with providing long-term energy security to supply energy in line with economic developments and sustainable environmental needs. Volatility in crude oil prices is also expected to provide significant growth opportunities to the bio-alcohol industry players.
Read more details about report at: https://www.alliedmarketresearch.com/bioalcohol-market
E-Waste Management Market is Expected to Reach $49.4 Billion, Globally, by 2020Allied Market Research
E-Waste Management Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $49.4 billion by 2020, registering a CAGR of 23.5% during the period 2014 - 2020.The ever-growing need for adapting the latest technology is the prime factor for a large volume of E-Waste generated across the globe. The Asia Pacific region contributes to the largest revenue share in the global E-Waste management market, followed by European countries. Analysis of the market indicates that the global volume of E-waste accounted for 57.7 million tons in 2013.
Multifamily housing has been on a continuous rise in the recent years, attributed to the increased preference of younger adults to reside in apartments, thus fuelling the demand for windows & doors. Read more https://www.alliedmarketresearch.com/press-release/windows-and-doors-market.html
3D Printing Market : Pin-Point Analysis of Industry Trends & Recent Technolog...Allied Market Research
3D Printing Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $8.6 billion by 2020, registering a CAGR of 21% during the period 2015-2020. This surge in growth is primarily attributed to the rising demand for faster and efficient ways to manufacture complex design objects using a wide array of materials.
Get Sample of this report : https://goo.gl/kTpMki
Sensor Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $241 billion by 2022, registering a CAGR of 11.3% during the period 2016-2022.
Get PDF Brochure : https://goo.gl/lpJSl3
Power Electronics Market To Have Steady Growth of $25 Billion by 2022Allied Market Research
Power Electronics Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $25 billion by 2022, registering a CAGR of 8.9% during the period 2016-2022. Asia-Pacific dominates the global market in terms of revenue, accounting for more than 50% share of the global market, followed by Europe.
Location Based Services Market Expected to Reach $61,897 Million by 2022, Glo...Allied Market Research
The Global Location-Based Services Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $61,897 million by 2022, registering a CAGR of 26.6% from 2016 to 2022. In 2015,Mapping and navigation application dominated the global location-based services market, in terms of revenue. North America is expected to be the leading revenue contributor during the forecast period.
Read more@ https://www.alliedmarketresearch.com/india-automotive-lighting-market
Key reasons that boost the Indian automotive lighting market are the technological advancements and increasing purchasing power. Based on vehicle type, the market is classified into passenger vehicles, commercial vehicles, two-wheelers, three-wheelers, and tractors. Passenger vehicles is estimated to be the largest vehicle type segment for automotive lighting. The demand for aesthetic lighting features is expected to support the demand for lights in compact cars as well as SUVs. The segment constituted nearly 45% of revenue in 2014.
Power Electronics Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $25 billion by 2022, registering a CAGR of 8.9% during the period 2016-2022. Asia-Pacific dominates the global market in terms of revenue, accounting for more than 50% share of the global market, followed by Europe.
Food Intolerance Products Market By Type (Diabetic Food, Gluten-free Food, La...Allied Market Research
Lactose-free food products and gluten-free food products segment held a prominent position with major revenue share and is projected to continue its dominance during the forecast period. Lactose-free dairy products and gluten-free bakery products are the major revenue generating sub segments in respective sectors
In-Car Infotainment Market is Expected to Reach $33.8 Billion, Globally by 2022Allied Market Research
In-Car Infotainment Market Report by Allied Market Research, The in-car infotainment market is expected to reach $33.8 billion by 2022, registering a CAGR of 13.3% during 2016 - 2022.
Access Full Summary at :https://www.alliedmarketresearch.com/in-car-infotainment-market
Thin Film Semiconductor Deposition Market to Reach $22 Billion, Globally, by ...Allied Market Research
According to a new report published by Allied Market Research, titled, Thin Film Semiconductor Deposition Market- Global Opportunity Analysis and Industry Forecast, 2014 - 2022", the global thin film semiconductor deposition market is expected to garner $22 billion by 2022, growing at a CAGR of 14% from 2016 to 2022.
Thin films are extensively used in applications such as DRAM, solar panels, and flexible OLED & AMOLED displays. Moreover, increase in demand for efficiency and circuit miniaturization has supplemented the growth of TFS deposition market.
Thin film deposition technology is bifurcated into three types that include, chemical vapor deposition (CVD), physical vapor deposition (PVD), and others. Among all, CVD technology holds a significant revenue share in the world TFS deposition market, owing to its low manufacturing cost, comparatively easier manufacturing process, and extensive use in fastest growing photovoltaic technology. In addition, CVD technology is expected to witness the fastest growth during the forecast period, with a CAGR of 14.7%. The growth would be driven by increase in demand of microelectronic components, electronic devices, and its expanding usage in sensors for smartphones which are growing rapidly across the globe.
Light Fidelity (Li-Fi)/Visible Light Communication Market to Reach $115 Billi...Allied Market Research
A new report published by Allied Market Research, titled, Light Fidelity (Li-Fi)/Visible Light Communication Market - Global Opportunity Analysis and Industry Forecast, 2014 - 2022, suggests that the global Li-Fi market is expected to reach $115 billion by 2022, growing at a CAGR of 116.8% from 2016 to 2022. In 2015, North America contributed major share in the market and will continue to lead throughout the forecast period.
Light Fidelity (Li-Fi) is a very high speed, two-way wireless communication method which uses visible light from LEDs as the medium for transmitting the data by turning them on and off at very high frequency which human eyes cannot sense. This technology is an apt replacement for currently prevailing Wi-Fi technology as Li-Fi is considerably faster, has almost 10,000 times broader bandwidth because it uses visible light, and it is safe to operate in electromagnetic sensitive areas
The world stents market would reach $16,666 million by 2022. A stent is a tube like implant that is implanted into the lumen of any blood vessel or a duct in order to keep the passage open. Varieties of stents for different clinical conditions are available in the market. A stent implant is most commonly used for the treatment of cardiac abnormalities such as blocked blood vessels. In addition, stents are implanted in the esophagus to allow the passage of food and beverages in patients suffering from esophageal cancer.
Read here at: https://www.alliedmarketresearch.com/stents-market
The global defibrillators market would reach $15,610 million by 2022. Defibrillators are devices used to deliver therapeutic shock to a patient’s heart in life-threatening conditions such as ventricular fibrillation, cardiac arrhythmia, and pulseless ventricular tachycardia. The defibrillation procedure encompasses delivery of an electric shock to the heart, which depolarizes heart muscles and restores its normal electric impulse. Growing focus towards public access defibrillator (PAD) by the public & private organizations has fueled the market growth.
read more at: https://www.alliedmarketresearch.com/defibrillator-market
Omega-3 market is expected to reach $6,955 million by 2022, with a CAGR of 14.9% from 2016 to 2022. Docosahexaenoic acid segment (DHA) dominated with three-fourths market share, in terms of revenue, in 2015. Dietary supplement application accounted for three-fifths of the global omega-3 market share, in terms of volume, in 2015 and is anticipated to grow at a CAGR of 14.1%.
Read more about this research at : https://www.alliedmarketresearch.com/omega-3-market
Discover the benefits of homeopathic medicine for irregular periods with our guide on 5 common remedies. Learn how these natural treatments can help regulate menstrual cycles and improve overall menstrual health.
Visit Us: https://drdeepikashomeopathy.com/service/irregular-periods-treatment/
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
Know the difference between Endodontics and Orthodontics.Gokuldas Hospital
Your smile is beautiful.
Let’s be honest. Maintaining that beautiful smile is not an easy task. It is more than brushing and flossing. Sometimes, you might encounter dental issues that need special dental care. These issues can range anywhere from misalignment of the jaw to pain in the root of teeth.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)MuskanShingari
Statistics- Statistics is the science of collecting, organizing, presenting, analyzing and interpreting numerical data to assist in making more effective decisions.
A statistics is a measure which is used to estimate the population parameter
Parameters-It is used to describe the properties of an entire population.
Examples-Measures of central tendency Dispersion, Variance, Standard Deviation (SD), Absolute Error, Mean Absolute Error (MAE), Eigen Value
Pictorial and detailed description of patellar instability with sign and symptoms and how to diagnose , what investigations you should go with and how to approach with treatment options . I have presented this slide in my 2nd year junior residency in orthopedics at LLRM medical college Meerut and got good reviews for it
After getting it read you will definitely understand the topic.
Summer is a time for fun in the sun, but the heat and humidity can also wreak havoc on your skin. From itchy rashes to unwanted pigmentation, several skin conditions become more prevalent during these warmer months.
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...Université de Montréal
“Psychiatry and the Humanities”: An Innovative Course at the University of Montreal Expanding the medical model to embrace the humanities. Link: https://www.psychiatrictimes.com/view/-psychiatry-and-the-humanities-an-innovative-course-at-the-university-of-montreal
Pune Call Girls 7339748667 AVAILABLE HOT GIRLS AUNTY BOOK NOW
Dna diagnostics market is making footprints across the globe
1. DNA diagnostics market is
making footprints across the
globe
Published Date: 27 August
2014
2. Introduction to DNA Diagnostics Market
DNA diagnostics is a cutting edge method which is set to revolutionize the field of
medical diagnostics. This technique enables medical professionals to identify
various diseases, such as cancer, infectious diseases, and myogenic disorders, and
to determine the appropriate treatment for the same. It is also used for clinical
diagnostic confirmation and in prenatal diagnostics.
The concept of DNA diagnostics has evolved via the breakthrough human genome
project that resulted in the discovery of various disease-causing agents.
3. Introduction to DNA Diagnostics Market
The DNA diagnostics market is expected to generate 19 billion by 2020, growing at a CAGR
of 9.8% during the analysis period. Technological development has played a major role in
improving DNA diagnostic platforms and techniques.
Some of the significant technologies which incorporate DNA diagnostics include polymerase
chain reaction (PCR), microarray techniques, sequencing technology and mass spectrometry;
these technologies are used for sample preparation, DNA isolation etc. Technological
developments, which have led to improvements in these methodologies, drive the growth of
the DNA diagnostics market.
The use of DNA diagnostic methods in prenatal diagnostics and clinical confirmation has also
boosted market growth. The DNA diagnostics market is expected to experience a growth
spurt in the foreseeable future. Innovations in product design and technology have prompted
doctors and researchers to shift their focus from traditional diagnostic methods to
personalized medicines.
The increased adoption of the personalized medicines approach would positively impact the
DNA diagnostics market in the foreseeable future. Next generation sequencing is a powerful
tool for decoding a number of human diseases, including various forms of cancer.
5. KEY BENEFITS
1. An in-depth analysis of various regions would provide a
clear understanding of current and future trends so that
companies can make region specific plans
2. The report studies the application of next generation
sequencing technology and biotechnology and their
impact on the DNA diagnostics market
3. A comprehensive analysis of the factors that drive and
restrict the growth of the DNA diagnostics market is
provided
4. Key regulatory guidelines in various regions which
impact the DNA diagnostics market are critically
examined
5. A quantitative analysis of the current market and
estimations through 2013-2020 are provided to
showcase the financial caliber of the DNA diagnostics
market
6. Table of Contents
1. INTRODUCTION
2. EXECUTIVE SUMMARY
3. MARKET OVERVIEW
4. GLOBAL DNA DIAGNOSTICS MARKET BY PRODUCT TYPES
5. GLOBAL DNA DIAGNOSTICS MARKET BY TECHNOLOGY, 2013-2020
6. GLOBAL DNA DIAGNOSTICS MARKET BY APPLICATIONS, 2013-2020
7. GLOBAL DNA DIAGNOSTIC MARKET BY END-USERS, 2013-2020
8. GLOBAL DNA DIAGNOSTIC MARKET BY GEOGRAPHY, 2013-2020
9. ASIA PACIFIC DNA DIAGNOSTIC MARKET ANALYSIS 2013-2020
7. DNA Diagnostic Market Overview
Market
Dynamics DNA
Diagnostic
Market
Overview
Patent
Analysis
Findings
Porter’s Five
force Analysis
Market
Definition &
Scope
Application of
Biotechnology
in DNA
Diagnostic
Key
Government
Regulations
Clinical Trials
8. MARKET DYNAMICS
Market Dynamics
Key
Market
Drivers
High cost involved
in research &
development
Key
Market
Restraint
Key
Market
Drivers
s
Increasing
incidences of
chronic and
infectious
diseases
Technological
Advancements
and product
modification
Increase in
popularity
personalized
medicine
approach
Unclear reimbursement
policies
&stringent
Government
regulation
9. GLOBAL DNA DIAGNOSTICS MARKET BY PRODUCT
TYPES
Instruments
DNA
DIAGNOSTICS
MARKET BY
PRODUCT
TYPES
Reagents
Software
&
Services
10. GLOBAL DNA DIAGNOSTICS MARKET BY
TECHNOLOGY, 2013-2020
DNA
DIAGNOSTICS
MARKET BY
TECHNOLOGY
PCR
Manufacturing Industry
Microarrays
In situ hybridization
Sequencing
Technology
Mass Spectrometry
Healthcare Industry
11. GLOBAL DNA DIAGNOSTICS MARKET BY
APPLICATIONS, 2013-2020
Oncology
Infectious disease testing
Myogenic disorder diagnosis
Clinical diagnosis confirmation
Prenatal diagnosis
Pre-implantation diagnosis
Others
12. Company Profiles
1. Sysmex
2. Bayer Diagnostic
3. Roche Diagnostics
4. Abbott Laboratories
5. Cephide Inc.
6. Gen-probe Inc. (Hologic)
7. Illumina, Inc.
8. Thermo Fisher Scientific
9. Bio-Rad Laboratories
10.Johnson and Johnson
13. GLOBAL DNA DIAGNOSTIC MARKET BY END-USERS,
2013-2020
Point of
Care
Central
Laboratories
Self Testing
DNA
DIAGNOSTIC
MARKET
BY
END-USERS
14. Your feedback is important to us
What would you like to know more about this Study ?
Global Industry Analysis
Market Size
Market Share
Market Trends
Opportunities and Forecast
Please inform us on : http://www.alliedmarketresearch.com/contact-us
15. Thank You!
For More Details
Visit us at
www.alliedmarketresearch.com
Follow Us On
16. To Browse the Complete Report
Visit :
http://www.alliedmarketresearch.
com/DNA-diagnostics-market